Boston Scientific (BSX) Non Operating Income (2009 - 2024)

Boston Scientific (BSX) has 16 years of Non Operating Income data on file, last reported at -$65.0 million in Q3 2024.

• For the quarter ending Q3 2024, Non Operating Income rose 21.69% year-over-year to -$65.0 million; the trailing twelve-month figure through Sep 2024 stood at -$311.0 million (down 9.12% YoY), and the FY2023 full-year result was -$358.0 million, up 29.53% from the prior year.
• Non Operating Income improved to -$65.0 million in Q3 2024, from -$100.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $257.0 million in Q4 2020 to a low of -$310.0 million in Q1 2022.
• A 5-year average of -$64.3 million and a median of -$79.0 million in 2023 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income jumped 531.82% in 2021 and sank 1216.67% in 2023, its largest moves.
• Tracing BSX's Non Operating Income over 5 years: stood at $257.0 million in 2020, then sank by 123.74% to -$61.0 million in 2021, then jumped by 90.16% to -$6.0 million in 2022, then slumped by 1216.67% to -$79.0 million in 2023, then rose by 17.72% to -$65.0 million in 2024.
• Business Quant data shows BSX's Non Operating Income at -$65.0 million in Q3 2024, -$100.0 million in Q2 2024, and -$67.0 million in Q1 2024.